A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This phase I trial will use the combination of irinotecan and BKM120 in patients with
advanced colorectal cancer who have failed on or have become intolerant of at least one line
of therapy for advanced colorectal cancer and who are candidates for irinotecan therapy.